The letter identifies quality system problems in a group of recalled devices and says monitoring software used with the pump requires premarket authorization.
J&J’s Abiomed hit with FDA warning letter over Impella heart pump Read More »
Kelly Bliss shared her thoughts on how the virtual care giant is approaching the three buzzy acronyms in an interview at HLTH.
AI, M&A and MSK: Teladoc’s head of group health shares vendor’s strategic priorities Read More »
The report from the Chair of the Senate HELP Committee calls for more federal oversight into nonprofit hospitals for providing minimal charity care “even as these hospitals saw a steady increase in their revenues and operating profits.”
Sanders targets nonprofit hospitals for not providing enough charity care Read More »
Sun Scientific, an innovative provider of compression and wound care solutions, is pleased to announce the appointment of Jeff Schultz as the new Vice President of Sales, North America.
Virion Therapeutics, LLC, and Ocean Biomedical, Inc. today announced they have entered into a joint venture to accelerate and expand Virion’s clinical-stage program and pipeline, with the goal of finding cures for patients with cancer and chronic infectious diseases.
Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program.
Aronora, Inc., a clinical-stage biotech poised to revolutionize blood clot treatment and prevention, today announced it has closed an investment from NYBC Ventures, a venture fund established by New York Blood Center.
Aronora Secures Investment From New York Blood Center Read More »
ReAlta Life Sciences was pleased to welcome Senator Mark R. Warner (D-Va) for an in-depth visit with the ReAlta management team, members of the ReAlta board of directors, and local investors on October 2, 2023.
HCA Healthcare’s Johnston-Willis Hospital in Richmond, Virginia, is the first hospital in the United States to provide treatment in a new clinical trial for patients with brain metastases from lung cancer.
BioCT is delighted to announce the appointment of David Scheer as Co-Chair of its Board of Directors.
BioCT appoints David Scheer as Co-Chair of the Board of Directors, welcomes new director Read More »
